According to Infant Bacterial Therapeutics AB's latest financial reports the company's current EPS (TTM) is -ยฃ0.49. In 2025 the company made an earnings per share (EPS) of -ยฃ0.39 an increase over its 2024 EPS that were of -ยฃ0.73.